Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CONTINUOUS-INFUSION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1595 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gately, S; Kerbel, R
      Antiangiogenic scheduling of lower dose cancer chemotherapy

      CANCER JOURNAL
    2. Atkins, MB; Dutcher, J; Weiss, G; Margolin, K; Clark, J; Sosman, J; Logan, T; Aronson, F; Mier, J
      Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part I.IL-2-based clinical trials

      MEDICAL ONCOLOGY
    3. Bowers, CY; Granda-Ayala, R
      Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH(2) and in combination in older men and women with decreased growth hormonesecretion

      ENDOCRINE
    4. Faradji, A; Bonnomet, F; Lecocq, J; Grunebaum, L; Desprez, D; Kern, O; Barbier, L; Sibilia, J
      Knee joint arthroplasty in a patient with haemophilia A and high inhibitortitre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature

      HAEMOPHILIA
    5. Chowdary, P; Dasani, H; Jones, JAH; Loran, CM; Eldridge, A; Hughes, S; Collins, PW
      Recombinant factor IX (BeneFix (R)) by adjusted continuous infusion: a study of stability, sterility and clinical experience

      HAEMOPHILIA
    6. Cid, AR; Lorenzo, JI; Haya, S; Montoro, JM; Casana, P; Aznar, JA
      A comparison of FVII : C and FVIIa assays for the monitoring of recombinant factor VIIa treatment

      HAEMOPHILIA
    7. Suresh, S; Anand, KJS
      Opioid tolerance in neonates: a state-of-the-art review

      PAEDIATRIC ANAESTHESIA
    8. Castagnola, E; Da Ros, L
      Temporary interruption of ceftazidime continuous infusion without reduction of activity: A computer-assisted simulation

      JOURNAL OF CHEMOTHERAPY
    9. Torres, LM; Rodriguez, MJ; Montero, A; Herrera, J; Calderon, E; Cabrera, J; Porres, R; de la Torre, MR; Martinez, T; Gomez, JL; Ruiz, J; Garcia-Magaz, I; Camara, J; Ortiz, P
      Efficacy and safety of dipyrone versus tramadol in the management of pain after hysterectomy: A randomized, double-blind, multicenter study

      REGIONAL ANESTHESIA AND PAIN MEDICINE
    10. Tetef, ML; Synold, TW; Chow, W; Leong, L; Margolin, K; Morgan, R; Raschko, J; Shibata, S; Somlo, G; Yen, Y; Groshen, S; Johnson, K; Lenz, HJ; Gandara, D; Doroshow, JH
      Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies

      CLINICAL CANCER RESEARCH
    11. Grem, JL; Danenberg, KD; Behan, K; Parr, A; Young, L; Danenberg, PV; Nguyen, D; Drake, J; Monks, A; Allegra, CJ
      Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the national cancer institute's anticancer drugscreen

      CLINICAL CANCER RESEARCH
    12. Schindler, J; Sausville, E; Messmann, R; Uhr, JW; Vitetta, ES
      The toxicity of deglycosylated ricin a chain-containing immunotoxins in patients with non-Hodgkin's lymphoma is exacerbated by prior radiotherapy: A retrospective analysis of patients in five clinical trials

      CLINICAL CANCER RESEARCH
    13. Kirstein, MN; Houghton, PJ; Cheshire, PJ; Richmond, LB; Smith, AK; Hanna, SK; Stewart, CF
      Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts

      CLINICAL CANCER RESEARCH
    14. Nasraway, SA
      Use of sedative medications in the intensive care unit

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    15. Sessler, CN; Grap, MJ; Brophy, GM
      Multidisciplinary management of sedation and analgesia in critical care

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    16. Poon, MC
      Use of recombinant factor VIIa in hereditary bleeding disorders

      CURRENT OPINION IN HEMATOLOGY
    17. Dillman, RO
      Monoclonal antibody therapy for lymphoma - An update

      CANCER PRACTICE
    18. Pass, SE; Miyagawa, CI; Healy, DP; Ivey, TD
      Serum concentrations of cefuroxime after continuous infusion in coronary bypass graft patients

      ANNALS OF PHARMACOTHERAPY
    19. Witzke, O; Winterhagen, T; Saller, B; Roggenbuck, U; Lehr, I; Philipp, T; Mann, K; Reinhardt, W
      Transient stimulatory effects on pituitary-thyroid axis in patients treated with interleukin-2

      THYROID
    20. Bookman, MA
      Developmental chemotherapy in advanced ovarian cancer: Incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    21. Kaufman, HL; DeRaffele, G; Divito, J; Horig, H; Lee, D; Panicali, D; Voulo, M
      A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma

      HUMAN GENE THERAPY
    22. Cartron, G; Voillat, L; Desablens, B; Le Maignan, C; Milpied, N; Foussard, C; Dugay, J; Maakaroun, A; De Muret, A; Colombat, P
      Continuous infusion of vincristine-doxorubicin with bolus of Dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    23. Dillman, RO; DeLeon, C; Beutel, LD; Barth, NM; Schwartzberg, LS; Spitler, LE; Garfield, DH; O'Connor, AA; Nayak, SK
      Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    24. Launois, R; Portafax, C; Le Lay, K; Megnigbeto, A; Perrocheau, G
      Internet pharmaco-economic studies in metastatic colorectal cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    25. Choy, H
      Taxanes in combined modality therapy for solid tumors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    26. Ianniello, GP; Orditura, M; Rossi, A; De Vita, F; Maiorino, L; Carrozza, F; Manzione, L; Catalano, G
      Gemcitabine plus epirubicin in advanced pancreatic cancer: A phase II multicenter trial

      ONCOLOGY REPORTS
    27. Berrak, SG; Ewer, MS; Jaffe, N; Pearson, P; Ried, K; Zietz, HA; Benjamin, RS
      Doxorubicin cardiotoxicity in children: Reduced incidence of cardiac dysfunction associated with continuous-infusion schedules

      ONCOLOGY REPORTS
    28. Bobbio-Pallavicini, E; Tacconi, F; Porta, C; Brambilla, G; Mainardi, E; Bianchessi, C; Moroni, M
      Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: A phase-II study

      ONCOLOGY REPORTS
    29. Yukimoto, K; Nakata, B; Muguruma, K; Yashiro, M; Ohira, M; Ishikawa, T; Hino, M; Hirakawa, K
      Apoptosis and thymidylate synthase inductions by 5-fluorouracil in gastriccancer cells with or without p53 mutation

      INTERNATIONAL JOURNAL OF ONCOLOGY
    30. Slifstein, M; Laruelle, M
      Models and methods for derivation of in vivo neuroreceptor parameters withPET and SPECT reversible radiotracers

      NUCLEAR MEDICINE AND BIOLOGY
    31. Schmid, P; Possinger, K
      Liposomal anthracyclines for improved cardiac tolerability

      BREAST
    32. D'Antiga, L; Baker, A; Pritchard, J; Pryor, D; Mieli-Vergani, G
      Veno-occlusive disease with multi-organ involvement following actinomycin-D

      EUROPEAN JOURNAL OF CANCER
    33. Maindrault-Goebel, F; de Gramont, A; Louvet, C; Andre, T; Carola, E; Mabro, M; Artru, P; Gilles, V; Lotz, JP; Izrael, V; Krulik, M
      High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)

      EUROPEAN JOURNAL OF CANCER
    34. Comba, AZ; Blajman, C; Richardet, E; Bella, S; Vilanova, M; Coppola, F; Van Kooten, M; Rodger, J; Giglio, R; Balbiani, L; Perazzo, F; Montiel, M; Chacon, M; Pujol, F; Mickiewicz, E; Cazap, E; Recondo, G; Lastiri, F; Simon, J; Wasserman, E; Schmilovich, A
      A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previouslyuntreated metastatic colorectal cancer patients

      EUROPEAN JOURNAL OF CANCER
    35. Cunningham, D; James, RD
      Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    36. Smorenburg, CH; Sparreboom, A; Bontenbal, M; Verweij, J
      Combination chemotherapy of the taxanes and antimetabolites: its use and limitations

      EUROPEAN JOURNAL OF CANCER
    37. Boucard, M; Pinguet, F; Poujol, S; Romieu, G; Cupissol, D; Astre, C; Culine, S; Bressolle, F
      Salivary and plasma pharmacokinetics of topotecan in patients with metastatic epithelial ovarian cancer

      EUROPEAN JOURNAL OF CANCER
    38. Alonso, V; Escudero, P; Zorrilla, M; Isla, MD; Herrero, A; Mayordomo, JI; Martinez-Trufero, J; Saenz, A; Tres, A; Anton, A
      Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    39. Garattini, S; La Vecchia, C
      Perspectives in cancer chemotherapy

      EUROPEAN JOURNAL OF CANCER
    40. Jagodic, M; Cufer, T; Zakotnik, B; Cervek, J
      Selection of candidates for oral etoposide salvage chemotherapy in heavilypretreated breast cancer patients

      ANTI-CANCER DRUGS
    41. Kehrer, DFS; Soepenberg, O; Loos, WJ; Verweij, J; Sparreboom, A
      Modulation of camptothecin analogs in the treatment of cancer: a review

      ANTI-CANCER DRUGS
    42. Wurthwein, G; Boos, J
      Simulation tool for schedule-dependent etoposide exposure based on pharmacokinetic findings published in the literature

      ANTI-CANCER DRUGS
    43. Jin, FL; Chung, F
      Multimodal analgesia for postoperative pain control

      JOURNAL OF CLINICAL ANESTHESIA
    44. Le Guen, H; Roy, D; Branger, B; Ecoffey, C
      Comparison of fentanyl and sufentanil in combination with bupivacaine for patient-controlled epidural analgesia during labor

      JOURNAL OF CLINICAL ANESTHESIA
    45. Molinari, AC; Castagnola, E; Mazzola, C; Piacentino, M; Fratino, G
      Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: a retrospective study of 362 catheters

      SUPPORTIVE CARE IN CANCER
    46. Matsota, P; Livanios, S; Marinopoulou, E
      Intercostal nerve block with bupivacaine for post-thoracotomy pain relief in children

      EUROPEAN JOURNAL OF PEDIATRIC SURGERY
    47. Erdlenbruch, B; Pekrun, A; Roth, C; Grunewald, RW; Kern, W; Lakomek, M
      Cisplatin nephrotoxicity in children after continuous 72-h and 3x1-h infusions

      PEDIATRIC NEPHROLOGY
    48. Nicolau, DP; McNabb, J; Lacy, MK; Quintiliani, R; Nightingale, CH
      Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    49. Glimelius, B
      Chemoradiotherapy for rectal cancer - is there an optimal combination?

      ANNALS OF ONCOLOGY
    50. Rosati, G; Rossi, A; Tucci, A; Pizza, C; Manzione, L
      Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer

      ANNALS OF ONCOLOGY
    51. Louvet, C; Andre, T; Hammel, P; Selle, F; Landi, B; Cattan, S; Fonck, M; Flesch, M; Colin, P; Balosso, J; Ruszniewski, P; de Gramont, A
      Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine foradvanced pancreatic adenocarcinoma (FOLFUGEM)

      ANNALS OF ONCOLOGY
    52. Saghatchian, M; Fizazi, K; Borel, C; Ducreux, M; Ruffie, P; Le Chevalier, T; Theodore, C
      Carcinoma of an unknown primary site: A chemotherapy strategy based on histological differentiation - results of a prospective study

      ANNALS OF ONCOLOGY
    53. Bonetti, A; Zaninelli, M; Leone, R; Franceschi, T; Fraccon, AP; Pasini, F; Sabbioni, R; Cetto, GL; Sich, D; Brienza, S; Howell, SB
      Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma

      ANNALS OF ONCOLOGY
    54. Gallardo, JO; Rubio, B; Fodor, M; Orlandi, L; Yanez, M; Gamargo, C; Ahumada, M
      A phase II study of gemcitabine in gallbladder carcinoma

      ANNALS OF ONCOLOGY
    55. Nole, F; Munzone, E; Mandala, M; Catania, C; Orlando, L; Zampino, MG; Minchella, I; Colleoni, M; Peruzzotti, G; Marrocco, E; Goldhirsch, A
      Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study

      ANNALS OF ONCOLOGY
    56. Shimizu, M; Tamura, T; Yamada, Y; Akiyama, Y; Saijo, N; Nishio, K
      CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNAin mouse liver

      JAPANESE JOURNAL OF CANCER RESEARCH
    57. Coleman, M; Leonard, J; Shuster, MW; Kaufman, TP
      DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL)

      EUROPEAN JOURNAL OF HAEMATOLOGY
    58. Jokinen, MJ; Ahonen, J; Neuvonen, PJ; Olkkola, KT
      Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine

      PHARMACOLOGY & TOXICOLOGY
    59. Khayat, D; Gil-Delgado, M; Antoine, EC; Nizri, D; Bastian, G
      The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer

      ONCOLOGY-NEW YORK
    60. Sun, WJ; Haller, DG
      The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer - The Khayat et al article reviewed

      ONCOLOGY-NEW YORK
    61. Haller, DG
      Update on chemotherapy for advanced colorectal cancer

      ONCOLOGY-NEW YORK
    62. Berlin, JD; Rothenberg, M
      Chemotherapy for resectable and advanced pancreatic cancer

      ONCOLOGY-NEW YORK
    63. Ahlgren, JD
      Chemotherapy for resectable and advanced pancreatic cancer - The Berlin/Rothenberg article reviewed

      ONCOLOGY-NEW YORK
    64. Bernstein, ML; Reaman, GH; Hirschfeld, S
      Developmental therapeutics in childhood cancer - A perspective from the Children's Oncology Group and the US Food and Drug Administration

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    65. Hunault-Berger, M; Milpied, N; Bernard, M; Jouet, JP; Delain, M; Desablens, B; Sadoun, A; Guilhot, F; Casassus, P; Ifrah, N
      Daunorubicin continuous infusion induces more toxicity than bolus infusionin acute lymphoblastic leukemia induction regimen: a randomized study

      LEUKEMIA
    66. Ahlmann, M; Lanvers, C; Lumkemann, K; Rossig, C; Freund, A; Baumann, M; Boos, J
      Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells

      LEUKEMIA
    67. Pereira, J; Lawlor, P; Vigano, A; Dorgan, M; Bruera, E
      Equianalgesic dose ratios for opioids: A critical review and proposals forlong-term dosing

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    68. Zhou, H; Shen, V; Dempster, DW; Lindsay, R
      Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat

      JOURNAL OF BONE AND MINERAL RESEARCH
    69. Chelly, JE; Greger, J; Gebhard, R; Coupe, K; Clyburn, TA; Buckle, R; Criswell, A
      Continuous femoral blocks improve recovery and outcome of patients undergoing total knee arthroplasty

      JOURNAL OF ARTHROPLASTY
    70. Green, SM; Denmark, TK; Cline, J; Roghair, C; Abd Allah, S; Rothrock, SG
      Ketamine sedation for pediatric critical care procedures

      PEDIATRIC EMERGENCY CARE
    71. Szokol, JW; Vender, JS
      Anxiety, delirium, and pain in the intensive care unit

      CRITICAL CARE CLINICS
    72. Young, CC; Prielipp, RC
      Benzodiazepines in tide intensive care unit

      CRITICAL CARE CLINICS
    73. Ibrahim, NK; Valero, V; Rahman, Z; Theriault, RL; Walters, RS; Buzdar, AU; Booser, DJ; Holmes, FA; Murray, DJ; Willey, J; Bast, R; Hortobagyi, GN
      Phase I-II vinorelbine (Navelbine((R))) by continuous infusion in patientswith metastatic breast cancer: Cumulative toxicities limit dose escalation

      CANCER INVESTIGATION
    74. Freyer, G; Bossard, N; Romestaing, P; Mornex, F; Chapet, O; Trillet-Lenoir, V; Gerard, JP
      Addition of oxaliplatin to continuous fluorouracil, L-folinic acid, and concomitant radiotherapy in rectal cancer: The Lyon R 97-03 Phase I trial

      JOURNAL OF CLINICAL ONCOLOGY
    75. Hoff, PM; Ansari, R; Batist, G; Cox, J; Kocha, W; Kuperminc, M; Maroun, J; Walde, D; Weaver, C; Harrison, E; Burger, HU; Osterwalder, B; Wang, AO; Wong, R
      Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study

      JOURNAL OF CLINICAL ONCOLOGY
    76. Dorr, R; Karanes, C; Spier, C; Grogan, T; Greer, J; Moore, J; Weinberger, B; Schiller, G; Pearce, T; Litchman, M; Dalton, W; Roe, D; List, AF
      Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    77. Becouarn, Y; Gamelin, E; Coudert, B; Negrier, S; Pierga, JY; Raoul, JL; Provencal, J; Rixe, O; Krisch, C; Germa, C; Bekradda, M; Mignard, D; Mousseau, M
      Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    78. Van Cutsem, E; Twelves, C; Cassidy, J; Allman, D; Bajetta, E; Boyer, M; Bugat, R; Findlay, M; Frings, S; Jahn, M; McKendrick, J; Osterwalder, B; Perez-Manga, G; Rosso, R; Rougier, P; Schmiegel, WH; Seitz, JF; Thompson, P; Vieitez, JM; Weitzel, C; Harper, P
      Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study

      JOURNAL OF CLINICAL ONCOLOGY
    79. Falcone, A; Di Paolo, A; Masi, G; Allegrini, G; Danesi, R; Lencioni, M; Pfanner, E; Comis, S; Del Tacca, M; Conte, P
      Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    80. Saylors, RL; Stine, KC; Sullivan, J; Kepner, JL; Wall, DA; Bernstein, ML; Harris, MB; Hayashi, R; Vietti, TJ
      Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: A pediatric oncology group phase II study

      JOURNAL OF CLINICAL ONCOLOGY
    81. Heinzer, H; Huland, E; Huland, H
      Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer

      WORLD JOURNAL OF UROLOGY
    82. Nolte, W; Ramadori, G
      New aspects in the palliative treatment of metastatic colorectal carcinoma

      MEDIZINISCHE KLINIK
    83. Locher, C; Auperin, A; Boige, V; Alzieu, L; Pignon, JP; Abbas, M; Ducreux, M
      Assessment of the cost of first line chemotherapy in metastatic colorectalcancer. Preliminary results in the FFCD 9601 trial

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    84. Louvet, C
      New chemotherapies for colorectal cancer treatment

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    85. Mimoz, O
      Antibiotic administration in Gram-negative bacilli infections.

      MEDECINE ET MALADIES INFECTIEUSES
    86. Oberhoff, C; Kieback, DG; Wurstlein, R; Deertz, H; Sehouli, J; van Soest, C; Hilfrich, J; Mesrogli, M; von Minckwitz, G; Staab, HJ; Schindler, AE
      Topotecan chemotherapy in patients with breast cancer and brain metastases: Results of a pilot study

      ONKOLOGIE
    87. Honecker, F; Wedding, U; Kolb, G; Bokemeyer, C
      Chemotherapy in colorectal cancer - Which therapy is justified in elderly patients?

      ONKOLOGIE
    88. Hartung, G
      New developments in chemotherapy of gastrointestinal carcinomas

      ONKOLOGIE
    89. Compton, P; Charuvastra, VC; Ling, W
      Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent

      DRUG AND ALCOHOL DEPENDENCE
    90. Wiig, H; Tenstad, O
      Interstitial exclusion of positively and negatively charged IgG in rat skin and muscle

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    91. Sanfilippo, NJ; Crane, CH; Skibber, J; Feig, B; Abbruzzese, JL; Curley, S; Vauthey, JN; Ellis, LM; Hoff, P; Wolff, RA; Brown, TD; Cleary, K; Wong, A; Phan, T; Janjan, NA
      T4 rectal cancer treated with preoperative chemoradiation to the posteriorpelvis followed by multivisceral resection: Patterns of failure and limitations of treatment

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    92. Fu, CH; Martin-Aragon, S; Weinberg, KI; Ardi, VC; Danenberg, PV; Avramis, VI
      Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    93. Morgan, RJ; Synold, T; Carr, BI; Doroshow, JH; Womack, EP; Shibata, S; Somlo, G; Raschko, J; Leong, L; McNamara, M; Chow, W; Tetef, M; Margolin, K; Akman, S; Longmate, J
      Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    94. Yule, SM; Price, L; Cole, M; Pearson, ADJ; Boddy, AV
      Cyclophosphamide metabolism in children following a 1-h and a 24-h infusion

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    95. Dowlati, A; Levitan, N; Gordon, NH; Hoppel, CL; Gosky, DM; Remick, SC; Ingalls, ST; Berger, SJ; Berger, NA
      Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    96. Herrington, JD; Figueroa, JA; Kirstein, MN; Zamboni, WC; Stewart, CF
      Effect of hemodialysis on topotecan disposition in a patient with severe renal dysfunction

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    97. van der Vorst, MMJ; van Heel, IRD; Kist-van Holthe, JE; den Hartigh, J; Schoemaker, RC; Cohen, AF; Burggraaf, J
      Continuous intravenous furosemide in haemodynamically unstable children after cardiac surgery

      INTENSIVE CARE MEDICINE
    98. Smith, MP; Ludlam, CA; Collins, PW; Hay, CRM; Wilde, JT; Grigeri, A; Melsen, T; Savidge, GF
      Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII - Plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding

      THROMBOSIS AND HAEMOSTASIS
    99. Santagostino, E; Morfini, M; Rocino, A; Baudo, F; Scaraggi, FA; Gringeri, A
      Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors

      THROMBOSIS AND HAEMOSTASIS
    100. Kerbusch, T; de Kraker, J; Mathot, RAA; Beijnen, JH
      Population pharmacokinetics of ifosfamide and its dechloroethylated and hydroxylated metabolites in children with malignant disease - A sparse sampling approach

      CLINICAL PHARMACOKINETICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 15:15:22